Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Yang, Min  [Clear All Filters]
Journal Article
Qian J-J, Hu X, Wang Y, Zhang Y, Du J, Yang M, Tong H, Bin Qian W-, Wei J, Yu W, et al. CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study. Cancer Med. 2020.
Li Y, Li Z, Yang M, Wang F, Zhang Y, Li R, Li Q, Gong Y, Wang B, Fan B, et al. Decoding the temporal and regional specification of microglia in the developing human brain. Cell Stem Cell. 2022.
Wang Y, Zhang T, Du H, Yang M, Xie G, Liu T, Deng S, Yuan W, He S, Wu D, et al. Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin. Oncol Rep. 2023;50(2).
Zhang H, Yang M, Wu X, Li Q, Li X, Zhao Y, Du F, Chen Y, Wu Z, Xiao Z, et al. The Distinct Roles of Exosomes in Tumor-Stroma Crosstalk within Gastric Tumor Microenvironment. Pharmacol Res. 2021:105785.
Niu H, An X, Wang X, Yang M, Cheng F, Lei A, Luo J. Dynamic role of Scd1 gene during mouse oocyte growth and differentiation. Int J Biol Macromol. 2023:125307.
Wang X, Diwu W, Guo J, Yan M, Ma W, Yang M, Bi L, Han Y. Enhancement of antibacterial properties and biocompatibility of TiAlV by graphene oxide/strontium nanocomposite electrodepositing. Biochem Biophys Res Commun. 2023;665:35-44.
Chen S, Liu J, Yang M, Lai W, Ye L, Chen J, Hou X, Ding H, Zhang W, Wu Y, et al. Fn14, a Downstream Target of the TGF-β Signaling Pathway, Regulates Fibroblast Activation. PLoS One. 2015;10(12):e0143802.
Li Z, Chen H, Feng X, Ruan Y, Yang M. Hematopoietic stem cell transplantation for CYBB heterozygous mutation resulting in very early onset inflammatory bowel disease in children: a case report. BMC Pediatr. 2023;23(1):348.
Huang J, Huang S, Ma Z, Lin X, Li X, Huang X, Wang J, Ye W, Li Y, He D, et al. Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation. Thromb Haemost. 2020.
Chen F, Che Z, Liu Y, Luo P, Xiao L, Song Y, Wang C, Dong Z, Li M, Tipoe GL, et al. Invigorating human MSCs for transplantation therapy via Nrf2/DKK1 co-stimulation in an acute-on-chronic liver failure mouse model. Gastroenterol Rep (Oxf). 2024;12:goae016.
Xiao S, Huang Q, Ren H, Yang M. The mechanism and function of super enhancer RNA. Genesis. 2021:e23422.
Shen H, Yang M, Li S, Zhang J, Peng B, Wang C, Chang Z, Ong J, DU P. Mouse totipotent stem cells captured and maintained through spliceosomal repression. Cell. 2021.
Li H, Rong P, Ma X, Nie W, Chen Y, Zhang J, Dong Q, Yang M, Wang W. Mouse Umbilical Cord Mesenchymal Stem Cell Paracrine Alleviates Renal Fibrosis in Diabetic Nephropathy by Reducing Myofibroblast Transdifferentiation and Cell Proliferation and Upregulating MMPs in Mesangial Cells. J Diabetes Res. 2020;2020:3847171.
Geng N, Yu Z, Zeng X, Xu D, Gao H, Yang M, Huang X. Nuclear Tubulin Enhances CXCR4 Transcription and Promotes Chemotaxis Through TCF12 Transcription Factor in human Hematopoietic Stem Cells. Stem Cell Rev Rep. 2023.
Wang B, Yang M, Li S. Numb and Numblike regulate sarcomere assembly and maintenance. J Clin Invest. 2022;132(3).
Yang T, Liang N, Zhang J, Bai Y, Li Y, Zhao Z, Chen L, Yang M, Huang Q, Hu P, et al. OCTN2 enhances PGC-1α-mediated fatty acid oxidation and OXPHOS to support stemness in hepatocellular carcinoma. Metabolism. 2023:155628.
Hu M, Wang H, Wang L, Yang M, Lou Y, Jin J. Outcome of adult T-lymphoblastic lymphoma depends on ALL-type chemotherapy, prognostic factors, and performance of allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore). 2018;97(28):e11374.
Wang C, Liu H, Yang M, Bai Y, Ren H, Zou Y, Yao Z, Zhang B, Li Y. RNA-Seq Based Transcriptome Analysis of Endothelial Differentiation of Bone Marrow Mesenchymal Stem Cells. Eur J Vasc Endovasc Surg. 2019.
Li Y, Li Z, Wang C, Yang M, He Z, Wang F, Zhang Y, Li R, Gong Y, Wang B, et al. Spatiotemporal transcriptome atlas reveals the regional specification of the developing human brain. Cell. 2023.
Wang H, Mao L, Yang M, Qian P, Lu H, Tong H, Xie W, Zhou D, Huang X, Wang Y, et al. Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial. Lancet Haematol. 2022.